Question/ food for thought.......if the "pending news" is in regard to "Urocidin-related" news....would Endo not have been halted at the same time? Impact of news affects both company's sp.
Hopefully a poster that has experienced a similar situation (in the past) relating to two companies with a financial tie can provide some history / background. Or, someone with strong regulatory knowledge.
Thank you in advance,
rg
individual investor (long & deep on BNC)